Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS)

CNY 4.08

(-1.69%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 4.78 Billion 4.86 Billion 5.06 Billion 5.22 Billion 5.61 Billion 6.47 Billion
Total Current Assets 2.06 Billion 2.04 Billion 1.71 Billion 2.28 Billion 2.72 Billion 3.12 Billion
Cash And Short Term Investments 699.46 Million 592.35 Million 379.62 Million 617.43 Million 1.02 Billion 550.79 Million
Cash and Cash Equivalents 699.46 Million 592.35 Million 379.62 Million 617.43 Million 1.02 Billion 550.79 Million
Short Term Investments - - -173.2 Million -175.58 Million -157.47 Million -198.33 Million
Net Receivables 746.15 Million 792.56 Million 750.74 Million 1.01 Billion 1.28 Billion 2.21 Billion
Inventory 586.65 Million 625.08 Million 554.62 Million 498.36 Million 410.55 Million 358.94 Million
Other Current Assets 36.21 Million 30.62 Million 34.98 Million 150.71 Million 554.87 Thousand 170.95 Thousand
Total Non-Current Assets 2.71 Billion 2.82 Billion 3.34 Billion 2.94 Billion 2.89 Billion 3.35 Billion
Net PPE 1.78 Billion 1.82 Billion 1.7 Billion 1.41 Billion 1.28 Billion 1.42 Billion
Good Will And Intangible Assets 494.92 Million 526.06 Million 1.15 Billion 973.7 Million 1.16 Billion 1.22 Billion
Good Will 164.03 Million 164.03 Million 777.66 Million 631.73 Million 772.44 Million 861.4 Million
Intangible Assets 330.88 Million 362.03 Million 378.53 Million 341.96 Million 393.58 Million 367.99 Million
Long-Term Investments 36.66 Million 37.46 Million 211.47 Million 216.73 Million 201.23 Million 239.93 Million
Tax Assets 238.68 Million 225.63 Million 202.27 Million 191.32 Million 179 Million 175.95 Million
Other Non Current Assets 154.46 Million 213.03 Million 72.4 Million 144.16 Million 62.04 Million 288.95 Million
Other Assets 0.00 1.00 1.00 1.00 - 1.00
Total Liabilities 1.47 Billion 1.67 Billion 1.5 Billion 1.76 Billion 1.89 Billion 2.56 Billion
Total Current Liabilities 929.58 Million 1.17 Billion 1.07 Billion 1.53 Billion 1.07 Billion 1.98 Billion
Account Payables 135.05 Million 149.42 Million 140.93 Million 107.96 Million 139.07 Million 192.96 Million
Tax Payables 7.53 Million 64.83 Million 78.89 Million 63.34 Million 96.03 Million 112.72 Million
Short Term Debt 573.95 Million 705.46 Million 574.6 Million 1.09 Billion 566.02 Million 994.82 Million
Deferred Revenue 29.52 Million 67.51 Million 349.31 Million 326.93 Million 324.48 Million 112.72 Million
Other Current Liabilities 191.05 Million 250.31 Million 14.52 Million 10.6 Million 42.71 Million 683.02 Million
Total Non Current Liabilities 543.09 Million 503.16 Million 426.19 Million 227.2 Million 822.67 Million 581.43 Million
Long-Term Debt 387.22 Million 372.33 Million 328.34 Million 94.38 Million 775.77 Million 515.29 Million
Deferred Revenue Non Current 106.31 Million 100.18 Million 67.59 Million 41.38 Million 37.72 Million 40.03 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 12.11 Million 649.44 Thousand 1.00 65.74 Million 1.00 17.17 Million
Other Liabilities - 1.00 1.00 - - -
Total Equity 3.2 Billion 3.18 Billion 3.56 Billion 3.46 Billion 3.72 Billion 3.91 Billion
Stock Holders Equity 3.06 Billion 3.04 Billion 3.5 Billion 3.36 Billion 3.6 Billion 3.45 Billion
Common Stock 791.92 Million 791.92 Million 791.92 Million 791.92 Million 791.92 Million 791.92 Million
Retained Earnings 1.3 Billion 1.21 Billion 1.64 Billion 1.5 Billion 1.76 Billion 1.63 Billion
Accumulated other comprehensive income 317.25 Million 299.06 Million 299.25 Million 297.11 Million 287.11 Million 281.8 Million
Common Stock Equity 3.06 Billion 3.04 Billion 3.5 Billion 3.36 Billion 3.6 Billion 3.45 Billion
Capital Lease Obligation 117.91 Million 29.29 Million 12.41 Million 9.14 Million 9.05 Million 17.17 Million
Total Investments 36.66 Million 37.46 Million 38.27 Million 41.15 Million 43.76 Million 41.59 Million
Total Debt 1.07 Billion 1.07 Billion 902.95 Million 1.18 Billion 1.34 Billion 1.51 Billion
Net Debt 379.62 Million 485.44 Million 523.32 Million 567.5 Million 318.41 Million 959.32 Million

Balance Sheet Charts